In patients with heart failure, statin treatment reduces Rac1 function, NADPH oxidase activity and levels of reactive oxygen species [70], a finding consistent with our observation that simvastatin pretreatment reduces IL-1β/bradykinin mediated microvascular hyperpermeability. The gene discussed is IL1B; the disease is heart failure.